Dignity Health, Catholic Health Initiatives Collaborating on Precision Medicine Program | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Dignity Health, Catholic Health Initiatives Collaborating on Precision Medicine Program

September 21, 2016
by Heather Landi
| Reprints
Click To View Gallery

San Francisco-based Dignity Health and the Englewood, Colo.-based Catholic Health Initiatives (CHI) are collaborating on a large, community-based precision medicine program that could be available to approximately 12 million patients annually.

Through Precision Medicine Alliance LLC, Dignity Health and CHI will offer patients from both health care systems diagnostic and treatment protocols based on their genetic and molecular profile information, according to a joint announcement from the two health systems.

The program will be available at nearly 150 hospitals and care centers across the U.S.

The alliance will initially focus on advanced diagnostic tumor profiling in cancer treatment and will later expand into other areas such as cancer and cardiovascular risk, and pharmacogenomics, according to both health systems. The program will also support oncology research by populating a database with the goal of creating a large collection of clinical cancer data.

The Precision Medicine Alliance will also integrate electronic medical records (EMRs) into a data-management infrastructure that will allow access to clinical expertise and clinical trial information. The plan is for the two health systems to partner with laboratories and bioinformatics companies nationwide to develop molecular tests specific to meet the needs of patients and clinicians.

“The Precision Medicine Alliance will provide community physicians with access to a wide range of diagnostic technology that is currently only available in academic medical centers. This will provide more accurate diagnoses, with personalized therapies tailored to each patient through community providers, where the vast majority of care happens,” Lloyd Dean, president and CEO of Dignity Health, said in a prepared statement. “Through our partnership with CHI, we are using the latest technology, especially in genomic sequencing, to deliver the right care, to the right patients, quickly and efficiently.”

Kevin E. Lofton, CEO of Catholic Health Initiatives, said in a statement, “Conventional wisdom suggests patients suffering from the same condition should be treated with the same therapy. Science now tells us that the efficacy of one-size fits all for medications and therapies varies by patient because each person has a unique DNA profile that responds differently to prevailing treatments. Through the new Precision Medicine Alliance, use of genomics for diagnosis and treatments enables a new degree of precision for identifying the most effective treatment and/or clinical trial for each patient, as well as those treatments that would potentially be ineffective or harmful. Through the program we will partner with laboratories and data solution companies nationwide to promote new clinical trial development and molecular tests to meet specific patient needs.”

Additionally, the Precision Medicine Alliance is aligned with the national Precision Medicine Initiative which is a $215 million investment from the White House to accelerate biomedical research and provide clinicians with new tools to select the therapies that will work best in individual patients.

“Current treatment programs largely focus on the best course of treatment for the general population,” Edward Abrahams, president of the Personalized Medicine Coalition, said. “However, with recent advancements in science and technology, the ability of personalized medicine to improve health outcomes for individuals and reduce toxicity due to adverse drug responses is great. Partnerships such as the one between Dignity Health and CHI that will bring this targeted approach directly to the communities is thrilling and will have a significant impact on patient lives and improving overall community health.”

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Duke Health First to Achieve HIMSS Stage 7 Rating in Analytics

North Carolina-based Duke Health has become the first U.S. healthcare institution to be awarded the highest honor for analytic capabilities by HIMSS Analytics.

NIH Releases First Dataset from Adolescent Brain Development Study

The National Institutes of Health (NIH) announced the release of the first dataset from the Adolescent Brain Cognitive Development (ABCD) study, which will enable scientists to conduct research on the many factors that influence brain, cognitive, social, and emotional development.

Boston Children's Accelerates Data-Driven Approach to Clinical Research

In an effort to bring a more data-driven approach to clinical research, Boston Children’s Hospital has joined the TriNetX global health research network.

Paper Records, Films Most Common Type of Healthcare Data Breach, Study Finds

Despite the high level of hospital adoption of electronic health records and federal incentives to do so, paper and films were the most frequent location of breached data in hospitals, according to a recent study.

AHA Appoints Senior Advisor for Cybersecurity and Risk

The American Hospital Association (AHA) has announced that John Riggi has joined the association as senior advisor for cybersecurity and risk.

Report: Healthcare Accounted for 45% of All Ransomware Attacks in 2017

Healthcare fell victim to more ransomware attacks than any other industry in 2017, according to a new report from global cybersecurity insurance company Beazley.